RETRACTED: Examining the lifespan of red blood cells in individuals with systemic lupus erythematosus
Clinical Hemorheology and Microcirculation · 2025
DOI: 10.1177/13860291241305508 ↗Kurz gefasst
Zurückgezogene Publikation in der Zeitschrift Clinical Hemorheology and Microcirculation, 2025. Verfasst von Pan Tian und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Longyan First Affiliated Hospital of Fujian Medical University, Fujian, People's Republic of China. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, COVID-19, Erythrocytes.
Abstract (Originalsprache)
ObjectiveThe objective of this study is to examine the lifespan of red blood cells (RBCs) in individuals with systemic lupus erythematosus (SLE), explore the factors influencing this lifespan, and assess its significance in clinical contexts.MethodsThe experimental group comprised of 182 patients with SLE, while the control group consisted of 90 healthy participants. By using a non-invasive breath test, we measured the RBC lifespan in both groups. Subsequently, we conducted a comparative analysis of general clinical data and laboratory findings to explore the correlation between RBC lifespan in patients with SLE and various parameters associated with RBC characteristics, inflammatory markers, and immunological indicators. Furthermore, we examined the impact of COVID-19 infection on RBC lifespan among patients with SLE and assessed the diagnostic efficacy of RBC lifespan.ResultsRBC lifespan was notably reduced in the SLE group in comparison to the healthy control group (P = 0.002). A positive correlation was observed between RBC lifespan and hemoglobin (HB), complement 3, and complement 4, whereas a negative correlation was noted with IgG, erythrocyte sedimentation rate (ESR), C-reactive protein, and anti-dsDNA levels (all P 0.05), a reduction in RBC lifespan post-COVID-19 infection was observed among patients with SLE (P < 0.05). Also, RBC lifespan was notably shorter during the active disease phase of SLE compared to the stable phase, with post-COVID-19 active patients with SLE exhibiting even shorter RBC lifespan compared to the pre-COVID-19 active group (all P < 0.05). An optimal cutoff for the prediction of anemia in patients with SLE on the day of assessment was determined to be 93.5 days (AUC 0.792, P < 0.05).ConclusionPatients with SLE exhibited shorter RBC lifespan in contrast to the healthy population, which is notably linked with levels of inflammatory and immune markers, as well as the incidence of COVID-19 infection. This discovery holds crucial significance for both the diagnosis of anemia and the comprehension of its underlying pathogenic mechanisms within the context of SLE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology, Longyan First Affiliated Hospital of Fujian Medical University, Fujian, People's Republic of China.
- Department of Infectious, The Second Hospital of Longyan, Fujian, People's Republic of China.
Zitieren
APA
Tian, P., Luo, F. L., Chen, A. Z., Yuan, Y. X., & Yu, L. (2025). RETRACTED: Examining the lifespan of red blood cells in individuals with systemic lupus erythematosus. Clinical Hemorheology and Microcirculation. https://doi.org/10.1177/13860291241305508
Vancouver
Tian P, Luo FL, Chen AZ, Yuan YX, Yu L. RETRACTED: Examining the lifespan of red blood cells in individuals with systemic lupus erythematosus. Clinical Hemorheology and Microcirculation. 2025. doi:10.1177/13860291241305508
BibTeX
@article{Tian2025,
author = {Tian, Pan and Luo, Feng-Lan and Chen, Ai-Zhen and Yuan, Yue-Xing and Yu, Lian},
title = {RETRACTED: Examining the lifespan of red blood cells in individuals with systemic lupus erythematosus},
journal = {Clinical Hemorheology and Microcirculation},
year = {2025},
doi = {10.1177/13860291241305508}
}
EUVIMED